FromAnalysistoAlpha:TheRealityofEmergingBiotechGrowth

We have a deep passion for the emerging biotech space, and it isn’t hard to see why. There is a unique fulfillment in identifying companies that are truly benefiting the world, gaining a profound understanding of their science, and supporting their growth in the market. Our mission is to translate complex data into actionable information. Days like today where we see a core conviction finally break through the 'algorithmic gauntlet' are beyond satisfying.

Our largest position, IBRX, which we have highlighted and documented through multiple strategic buys in our portfolio over the last few weeks, surged 40% today. As a founder and scientist focused on creating real wealth for my subscribers, there is no better feeling than seeing our thesis proven right by the market.

This is just the beginning. We have a pipeline of potential winners, and I am working nonstop to unearth the next breakthrough. The science is moving fast, and we are moving with it.